
MBX Biosciencesrevenue & market cap
Carmel, IndianaFounded 2019
Public companyMBX Biosciences, Inc. is a clinical-stage biopharmaceutical company focused on the discovery and development of novel precision peptide therapies for the treatment of endocrine and metabolic disorders.
MBX Biosciences revenue
MBX Biosciences has not published its revenue, and GetLatka has no sourced estimate yet. Know the figure? Send us a source.
MBX Biosciences market cap
MBX Biosciences is a public company. Its market capitalisation was $2.8B in September 2026.
Categories
How this page is sourced
Founder figures link to the second they were said; public figures name their source; estimates are marked EST and say whose they are. Not financial advice.
Updated Sep 28, 2026Data disclaimerReport a correctionClaim this profileRun MBX Biosciences? Join the podcast